Homeodomain-interacting protein kinase 2
Definition:
References:
-
[1]. Magdalena C Liebl, et al. DAZAP2 acts as specifier of the p53 response to DNA damage. Nucleic Acids Res. 2021 Mar 18;49(5):2759-2776. [Content Brief]
[2]. E Gresko, et al. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene. 2009 Feb 5;28(5):698-708. [Content Brief]
[3]. Ana Roscic, et al. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell. 2006 Oct 6;24(1):77-89. [Content Brief]
[4]. Thomas G Hofmann, et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol. 2002 Jan;4(1):1-10. [Content Brief]
[5]. Yutaka Shima, et al. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol. 2008 Dec;28(23):7126-38. [Content Brief]
[6]. Hee-Jun Wee, et al. PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. Blood. 2008 Nov 1;112(9):3777-87. [Content Brief]
[7]. Ki Sa Sung, et al. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53. Exp Cell Res. 2011 Apr 15;317(7):1060-70. [Content Brief]
[8]. Kiros Hailemariam, et al. Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress. J Cell Sci. 2010 Nov 15;123(Pt 22):3863-71. [Content Brief]
[9]. D Yamada, et al. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4. Oncogene. 2009 Jul 9;28(27):2535-44. [Content Brief]
[10]. Richard Tomasini, et al. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem. 2003 Sep 26;278(39):37722-9. [Content Brief]
[11]. Eun-Joo Kim, et al. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem. 2002 Aug 30;277(35):32020-8. [Content Brief]
[12]. Federico Pelisch, et al. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J Biol Chem. 2012 Aug 31;287(36):30789-99. [Content Brief]
[13]. Eun-A Kim, et al. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation. Biochem Biophys Res Commun. 2010 Apr 16;394(4):966-71. [Content Brief]
[14]. Thomas G Hofmann, et al. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res. 2003 Dec 1;63(23):8271-7. [Content Brief]
[15]. Lavinia Nardinocchi, et al. Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth. Biochim Biophys Acta. 2009 Feb;1793(2):368-77. [Content Brief]
[16]. Qingchun Zhang, et al. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. J Proteome Res. 2007 Dec;6(12):4711-9. [Content Brief]
[17]. Rong An, et al. Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization. Biochem Biophys Res Commun. 2010 Aug 20;399(2):155-61. [Content Brief]
[18]. Jun Harada, et al. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J Biol Chem. 2003 Oct 3;278(40):38998-9005. [Content Brief]
[19]. Kensuke Sakamoto, et al. Regulation of genotoxic stress response by homeodomain-interacting protein kinase 2 through phosphorylation of cyclic AMP response element-binding protein at serine 271. Mol Biol Cell. 2010 Aug 15;21(16):2966-74. [Content Brief]